These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 25048722)

  • 1. CYR61 overexpression associated with the development and poor prognosis of ovarian carcinoma.
    Shen H; Cai M; Zhao S; Wang H; Li M; Yao S; Jiang N
    Med Oncol; 2014 Aug; 31(8):117. PubMed ID: 25048722
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cysteine-rich, angiogenic inducer, 61 expression in patients with ovarian epithelial carcinoma.
    Lin Y; Xu T; Tian G; Cui M
    J Int Med Res; 2014 Apr; 42(2):300-6. PubMed ID: 24595148
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overexpression of SGLT1 is correlated with tumor development and poor prognosis of ovarian carcinoma.
    Lai B; Xiao Y; Pu H; Cao Q; Jing H; Liu X
    Arch Gynecol Obstet; 2012 May; 285(5):1455-61. PubMed ID: 22159627
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overexpression of RFC3 is correlated with ovarian tumor development and poor prognosis.
    Shen H; Cai M; Zhao S; Wang H; Li M; Yao S; Jiang N
    Tumour Biol; 2014 Oct; 35(10):10259-66. PubMed ID: 25030735
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression and prognostic significance of THBS1, Cyr61 and CTGF in esophageal squamous cell carcinoma.
    Zhou ZQ; Cao WH; Xie JJ; Lin J; Shen ZY; Zhang QY; Shen JH; Xu LY; Li EM
    BMC Cancer; 2009 Aug; 9():291. PubMed ID: 19698122
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CYR61, a potential biomarker of tumor inflammatory response in epithelial ovarian cancer microenvironment of tumor progress.
    Shi J; Huo R; Li N; Li H; Zhai T; Li H; Shen B; Ye J; Fu R; Di W
    BMC Cancer; 2019 Nov; 19(1):1140. PubMed ID: 31766991
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Cyr61 expression influences cancer cell proliferation and apoptosis via PI3K pathway in human ovarian carcinoma cells].
    Xiao L; He C; Li X; Chen Y; Zhou JD
    Zhonghua Fu Chan Ke Za Zhi; 2012 Aug; 47(8):616-20. PubMed ID: 23141184
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of Cyr61, CTGF, and WISP-1 correlates with clinical features of lung cancer.
    Chen PP; Li WJ; Wang Y; Zhao S; Li DY; Feng LY; Shi XL; Koeffler HP; Tong XJ; Xie D
    PLoS One; 2007 Jun; 2(6):e534. PubMed ID: 17579708
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High expression of transcriptional coactivator p300 correlates with aggressive features and poor prognosis of hepatocellular carcinoma.
    Li M; Luo RZ; Chen JW; Cao Y; Lu JB; He JH; Wu QL; Cai MY
    J Transl Med; 2011 Jan; 9():5. PubMed ID: 21205329
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of Cyr61 in primary salivary adenoid cystic carcinoma and its relation to Ki-67 and prognosis.
    Tang QL; Fan S; Li HG; Chen WL; Shen XM; Yuan XP; Chang SH; Song Y
    Oral Oncol; 2011 May; 47(5):365-70. PubMed ID: 21439895
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Overexpression of the embryonic-lethal abnormal vision-like protein HuR in ovarian carcinoma is a prognostic factor and is associated with increased cyclooxygenase 2 expression.
    Denkert C; Weichert W; Pest S; Koch I; Licht D; Köbel M; Reles A; Sehouli J; Dietel M; Hauptmann S
    Cancer Res; 2004 Jan; 64(1):189-95. PubMed ID: 14729623
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Relationship of cysteine-rich protein 61 and NF-kappaB expression with metastasis and prognosis of gastric carcinoma].
    Ma HF; Zhao ZS
    Zhonghua Bing Li Xue Za Zhi; 2008 Dec; 37(12):815-21. PubMed ID: 19159527
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inverse expression of cystein-rich 61 (Cyr61/CCN1) and connective tissue growth factor (CTGF/CCN2) in borderline tumors and carcinomas of the ovary.
    Bartel F; Balschun K; Gradhand E; Strauss HG; Dittmer J; Hauptmann S
    Int J Gynecol Pathol; 2012 Sep; 31(5):405-15. PubMed ID: 22833079
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overexpression of the recently identified oncogene REDD1 correlates with tumor progression and is an independent unfavorable prognostic factor for ovarian carcinoma.
    Chang B; Meng J; Zhu H; Du X; Sun L; Wang L; Li S; Yang G
    Diagn Pathol; 2018 Nov; 13(1):87. PubMed ID: 30428884
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Downregulated Long Noncoding RNA DGCR5 Acts as a New Promising Biomarker for the Diagnosis and Prognosis of Ovarian Cancer.
    Chen H; Tian X; Luan Y; Lu H
    Technol Cancer Res Treat; 2019; 18():1533033819896809. PubMed ID: 31868103
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cyr61, a member of ccn (connective tissue growth factor/cysteine-rich 61/nephroblastoma overexpressed) family, predicts survival of patients with endometrial cancer of endometrioid subtype.
    Watari H; Xiong Y; Hassan MK; Sakuragi N
    Gynecol Oncol; 2009 Jan; 112(1):229-34. PubMed ID: 19007976
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased expression of microRNA-196a predicts poor prognosis in human ovarian carcinoma.
    Fan Y; Fan J; Huang L; Ye M; Huang Z; Wang Y; Li Q; Huang J
    Int J Clin Exp Pathol; 2015; 8(4):4132-7. PubMed ID: 26097603
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Decreased expression of PinX1 protein is correlated with tumor development and is a new independent poor prognostic factor in ovarian carcinoma.
    Cai MY; Zhang B; He WP; Yang GF; Rao HL; Rao ZY; Wu QL; Guan XY; Kung HF; Zeng YX; Xie D
    Cancer Sci; 2010 Jun; 101(6):1543-9. PubMed ID: 20367640
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High expression of NQO1 is associated with poor prognosis in serous ovarian carcinoma.
    Cui X; Li L; Yan G; Meng K; Lin Z; Nan Y; Jin G; Li C
    BMC Cancer; 2015 Apr; 15():244. PubMed ID: 25885439
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Decreased expression of Beclin 1 correlates closely with Bcl-xL expression and poor prognosis of ovarian carcinoma.
    Lin HX; Qiu HJ; Zeng F; Rao HL; Yang GF; Kung HF; Zhu XF; Zeng YX; Cai MY; Xie D
    PLoS One; 2013; 8(4):e60516. PubMed ID: 23573264
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.